Sustainability Management
Sustainability Policy
Our corporate identity is "Contributing to the realization of a healthy society through the latest optimal medical device technologies". As a company that deals with medical devices, we aim to enhance our corporate value by pursuing not only the economic value of providing excellent medical devices to patients and medical professionals, but also the social value of realizing a healthy society. In addition to practicing our management philosophy, we will also focus on strengthening the foundation that will enable us to achieve sustainable growth over the medium to long term by implementing various initiatives to promote sustainability in order to meet the expectations and demands of the various stakeholders surrounding us.
By strengthening our sustainability-related initiatives and aiming for sustainable enhancement of corporate value, we will meet the expectations of our various stakeholders, including patients, medical professionals, employees, business partners, local communities and shareholders and investors.
Please click here to view other policies.
Multi-Stakeholder Policy (Japanese only) (153KB)
Environmental Conservation Policy
Sustainability Promotion Structure
We have established a Sustainability Committee to coordinate and promote company-wide activities related to sustainability. The committee, chaired by the president and CEO, is composed of executive directors who, in principle, direct, coordinate, and confirm the progress of activities of subcommittees that promote individual initiatives, and report to the Board of Directors on a quarterly basis.
In addition, a subcommittee is established for each materiality, and the executive director is responsible for promoting specific initiatives.
Identifying Materiality
Materiality Identification Process
In June 2021, we identified the materiality (important issues) shown as below.
<Procedures for Identifying Materiality>
STEP1.Identifying Social Issues
Identified social issues by referring to evaluation items in international sustainability guidelines (GRI, SASB, SDGs). Created a comprehensive long list of social issues and organized the items to create a short list of social issues (27 items).
STEP2.Prioritizing Social Issues
Evaluated and prioritized individual social issues by using the two axes of "importance to the company" and "importance to stakeholders.”
Created a matrix and selected candidates for the materiality that should be prioritized and initiated by the company.
STEP3.Validation
Confirmed the validity of the selected candidates of materiality through discussions by the members of the board.
STEP4.Identifying materiality
Organized the identified materiality into the following two categories.
“Issues to be Resolved Through the Business”
“Issues to be Addressed to Strengthen the Business Foundation”
Starting from the identified materiality, we will promote sustainability-related initiatives through setting KPIs and targets, developing a roadmap, implementing initiatives, monitoring progress, and disclosing information of the results.
Materiality
We categorize the 7 materiality into 2 categories, “issues to be resolved through the business” and “issues to be addressed to strengthen the business foundation” and set major theme for each materiality.
● Issues to be Resolved through the Business
Area | Materiality | Major Theme |
---|---|---|
Philosophy
Realizing a Healthy Society
|
Solve Medical Issues Through Innovative Medical Devices |
|
● Issues to be Addressed to Strengthen the Business Foundation
Area | Materiality | Major Theme |
---|---|---|
Environment
Consideration for the Global Environment
|
Reduce environmental impact |
|
Social
Creating a Rewarding WorkplaceSupply of Safe and Reliable Products |
Creat a workplace where employees can work with comfort |
|
Develop human resources and provide opportunities for them to play an active role |
|
|
Secure product quality and stable supply |
|
|
Governance
Acts as a Responsible Company
|
Strengthen corporate governance |
|
Promote compliance |
|
KPI and Progress
The Sustainability Committee has established a vision of what we want to be by 2030 for each materiality, and has set medium-term targets to achieve these targets through the fiscal year ending March 31, 2025. The subcommittee takes the lead in formulating KPI's and working toward achieving them.
Materiality | Major Themes | KPI | SDGs |
---|---|---|---|
Solve medical issues through innovative medical devices |
Improve technology for in-house products |
|
![]() ![]() |
Introduce medical devices with high clinical value |
|
||
Reduce environmental impact | Use resources efficiently |
|
![]() ![]() |
Reduce greenhouse gases |
|
||
Reduce waste / Process waste properly |
|
||
Create a workplace where employees can work with comfort | Create a comfortable work environment |
|
![]() ![]() |
Respect human diversity |
|
||
Respect human rights |
|
||
Develop human resources and provide opportunities for them to play an active role | Support employees to achieve specialized skills and personal goals |
|
![]() |
Strengthen education and training |
|
||
Secure product quality and stable supply | Strengthen the quality control system |
|
![]() |
Secure stable supply of products |
|
||
Strengthen corporate governance | Strengthen auditing and supervisory functions Execute management decision and operation with objectivity and transparency |
|
![]() ![]() |
Strengthen risk management initiatives |
|
||
Promote compliance | Ensure fairness and transparency in corporate activities |
|
![]() |
Solve medical issues through innovative medical devices
Our management philosophy is "to contribute to the realization of a healthy society through the latest and most appropriate medical devices.
Our value creation is based on the continuous delivery of innovative medical devices to the medical community.
We will secure our technological competitive advantage by developing new proprietary technologies through focused investment in R&D and patenting the results. We would like to meet the needs of medical professionals by introducing overseas advanced medical devices in Japan,applying our proprietary technologies to the development of products in other fields besides cardiovascular diseases.
KPI | Medium-Term Targets (by FY3/2025) | FY3/2023 results |
---|---|---|
R&D expenses |
|
2,316 million yen |
Number of patent applications |
|
34 patents |
Exploring new areas of business from Intellectual Property |
|
ー |
Introduction of user-friendly in-house products/purchased products Expansion and application of proprietary technologies to other fields |
|
Introduction of one-of-a-kind products 1 item |
Reduce environmental impact
The impact of environmental problems on sustainability, such as an increase in natural disasters due to global warming and marine pollution caused by plastic waste, has become a major social issue.
We are actively working to reduce our environmental impact over the medium to long term by establishing policies and systems for environmental preservation. We will contribute to the preservation of the global environment by reducing CO2 emissions and improving the industrial waste recycling rate through our business activities.
KPI | Medium-Term Targets (by FY3/2025) | FY3/2023 results |
---|---|---|
Establishment of an environmental policy and promotion system |
|
Formulation of Environmental Conservation Policy |
CO2 emissions |
|
6,612t |
Industrial waste recycling rate |
|
96% |
Create a workplace where employees can work with comfort
Employees are an important management resource supporting our business activities, and an environment in which all employees can work while making the most of their diversity is important for the sustainable growth of the company.
We are committed to creating an environment where each employee can work with vitality and enthusiasm by improving work-life balance and promoting understanding of diversity. In addition, we will formulate policies to respect the human rights of all stakeholders involved in our business and promote educational activities.
KPI | Medium-Term Targets (by FY3/2025) | FY3/2023 results |
---|---|---|
Assessment on the current status and implementation of measures to improve work-life balance |
|
Grasping the actual working hours per person per year(1941.7h) |
Ratio of female managers |
|
2.6% |
Reinforcement on efforts to reduce human rights risks |
|
Formulation of human rights policy |
Develop human resources and provide opportunities for them to play an active role
Employees are important management resources that create the company's competitive advantage, and their growth through new challenges will enhance the company's corporate value over the long term.
We will continue to actively invest in human resources by establishing policies and systems for human resource development. By implementing measures to improve employee satisfaction and providing training opportunities that promote growth, we will continue to create an environment in which each employee can work with a sense of fulfillment.
KPI | Medium-Term Targets (by FY3/2025) | FY3/2023 results |
---|---|---|
Formulation of human resources policy and establishment of human resources development promotion system |
|
Establishment of human resources development promotion system |
Improvement of employee satisfaction |
|
|
Education and training expenses per employee |
|
97,142 yen |
Secure product quality and stable supply
The medical devices we handle include many products that may affect the lives of patients.Therefore, ensuring the reliability of their quality is an important management issue. We will promote efforts to continuously improve the quality of our products by complying with not only Japanese domestic standards but also global regulatory requirements.
The medical devices we handle include one-of-a-kind products, and it is our social mission to continue to provide a stable supply of products to the medical field. We will strengthen our product supply chain system by promoting supplier risk management and the duplication of production lines.
KPI | Medium-Term Targets (by FY3/2025) | FY3/2023 results |
---|---|---|
Compliance with global regulatory requirements (Acquire MDSAP certificate) |
|
Completion of MDSAP application |
Maintain and improve the quality of our in-house products |
|
ー |
Percentage of supplier risk assessment surveys conducted |
|
100% |
Promotion of production line duplication |
|
|
Diversification and internalization of outsourcing of critical components and subcontracted processing |
|
ー |
*Medical Device Single Audit Program
MDSAP is a program that verifies the conformity and adequacy of a manufacturer's QMS to the regulatory requirements of regulatory authorities in five countries (the United States, Australia, Brazil, Canada, and Japan) in a single survey by an accredited survey organization.
Strengthen corporate governance
In order to achieve sustainable growth in the midst of a drastically changing external environment, it is necessary to establish a corporate governance system that increases management transparency and ensures prompt decision-making and its execution and supervision. We aim to enhance our corporate value by steadily promoting compliance with the Corporate Governance Code.
In recent years, the diversification of risks surrounding companies has made risk management more important than ever. We will strive to reduce risks by reassessing and deciding on measures to address company-wide risks and by strengthening information security measures.
KPI | Medium-Term Targets (by FY3/2025) | FY3/2023 results |
---|---|---|
Implementation of measures to comply with the Corporate Governance Code |
|
Appointment of one additional outside director to the Nomination and Remuneration Advisory Committee |
Promotion of risk management |
|
|
Reinforcement on information security measures |
|
Conduct training for all employees (2 times) |
Promote of Compliance
As a company that handles medical devices that can affect the lives of patients, we recognize that each of our employees is required to not only comply with laws and regulations, but also to have a higher sense of ethics in their actions.
We believe that practicing compliance means meeting the expectations of all stakeholders involved in our business, and we aim to be a company that continues to be trusted by society through compliance awareness activities.
KPI | Medium-Term Targets (by FY3/2025) | FY3/2023 results |
---|---|---|
Strengthening of the compliance system |
|
Conducting various training programs for all employees and job-specific |
Promotion of efforts to improve understanding of the whistleblower system |
|
|